Synthetic multi-layer nanoparticles for CRISPR-Cas9 genome editing.

Area of Science:

• Biotechnology
• Molecular Biology
• Gene Therapy

Background:

• Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technology offers revolutionary potential in biomedical research and disease treatment.
• Efficient delivery of CRISPR-Cas9 components is crucial for successful genome editing and therapeutic applications.
• Optimization of CRISPR delivery vehicles remains a significant challenge in the field.

Purpose of the Study:

• To review the development of CRISPR-Cas9 systems and their therapeutic applications.
• To highlight multi-layer nanoparticles (NPs) as advanced delivery vehicles for CRISPR cargos.
• To discuss challenges and potential solutions for developing CRISPR-based pharmaceuticals.

Main Methods:

• Summarizing current CRISPR-Cas9 based clinical trials.
• Reviewing various non-viral vectors, particularly multi-layer nanoparticles, for CRISPR delivery.
• Analyzing potential building blocks for multi-layer NPs.

Main Results:

• CRISPR-Cas9 systems are advancing towards therapeutic applications, with ongoing clinical trials.
• Multi-layer nanoparticles show promise as effective non-viral vectors for delivering CRISPR payloads in vitro and in vivo.
• Various materials and structures are being explored for constructing these advanced NPs.

Conclusions:

• Efficient delivery of CRISPR systems is paramount for realizing their full therapeutic potential.
• Multi-layer nanoparticles represent a promising strategy for overcoming current CRISPR delivery obstacles.
• Addressing efficiency and biosafety concerns is essential for translating CRISPR technology into viable pharmaceutical products.